A study published in PLOS ONE demonstrated that topical application of a tetravalent peptide resolved eczema in mouse models within 14 days, restoring normal epidermal morphology
This multimodal mechanism capitalizes on the inherent metabolic vulnerabilities of tumors, particularly their dysregulated redox homeostasis and elevated copper levels compared to normal tissues [113]
In contrast, downregulated proteins were mainly associated with pathways involving platelet aggregation, chylomicron clearance, and defective coagulation factor IX activation, among others (Figure 5C)
Our MOTS-c benefits guide covers the broader applications of this peptide, and the MOTS-c dosage chart provides specific protocol information
PMID: 29606813
These findings suggest a potentially paradigm-changing alternative to traditional antidepressants, concluded the authors